DEFLAZACORT ORAL SUSPENSION

DEFLAZACORT ORAL SUSPENSION is FDA application ANDA217813, sponsored by TRIS PHARMA INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.